MoneyWorks4Me

Biocon informs about company statement

26 Oct 2026 Evaluate
Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Secures Market Entry for Yesintek™, a Proposed Biosimilar to Stelara®, in Additional Global Markets’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1303.00
Cipla 1353.00
Lupin 1950.00
Zydus Lifesciences 1158.10
View more..